Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.630
+0.080 (3.14%)
Dec 20, 2024, 4:00 PM EST - Market closed
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 10 employees as of March 31, 2024. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
$1,354,700
Profits / Employee
-$368,600
Market Cap
3.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Check-Cap | 85 |
| Sharps Technology | 57 |
| Hepion Pharmaceuticals | 22 |
| HeartSciences | 15 |
| Autonomix Medical | 8 |
| Pasithea Therapeutics | 8 |
| Synaptogenix | 5 |
| Creative Medical Technology Holdings | 4 |
SNOA News
- 16 days ago - Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices - Accesswire
- 4 weeks ago - Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - Accesswire
- 5 weeks ago - Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - Accesswire
- 6 weeks ago - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - Accesswire
- 7 weeks ago - Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - Accesswire
- 2 months ago - Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - Accesswire
- 3 months ago - Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule - Accesswire